Skip to main content
Joerg Ermann, MD, Rheumatology, Boston, MA

JoergErmannMD

Rheumatology Boston, MA

Spondyloarthropathy

Assistant Professor of Medicine, Harvard Medical School and Brigham and Women's Hospital

Dr. Ermann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ermann's full profile

Already have an account?

  • Office

    60 Fenwood Road
    HBTM Room 6002P
    Boston, MA 02115
    Phone+1 617-525-1227
    Fax+1 617-525-1010

Summary

  • Dr. Joerg Ermann is a rheumatologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital and Brigham and Women's Faulkner Hospital. He received his medical degree from University of Leipzig Faculty of Medicine and has been in practice 16 years. He also speaks multiple languages, including German. He specializes in spondyloarthritis.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Rheumatology, 2006 - 2010
  • University of Tennessee
    University of TennesseeResidency, Internal Medicine, 2004 - 2006
  • University of Leipzig Faculty of Medicine
    University of Leipzig Faculty of MedicineClass of 1994

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2007 - 2026
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Press Mentions

  • Extra-Musculoskeletal Manifestations in Axial Spondyloarthritis
    Extra-Musculoskeletal Manifestations in Axial SpondyloarthritisDecember 13th, 2024
  • Lack of ‘Good Disease Model’ Inhibits Treatment Decision-Making in Axial Spondyloarthritis
    Lack of ‘Good Disease Model’ Inhibits Treatment Decision-Making in Axial SpondyloarthritisMay 7th, 2023
  • The Effects of IL-17A Inhibitors on the Microbiota
    The Effects of IL-17A Inhibitors on the MicrobiotaFebruary 16th, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • German